The performance of BD FACSPresto™ for CD4 T-cell count, CD4% and hemoglobin concentration test in Ethiopia.

In Ethiopia, CD4+ T-cell counting is still required for all patients at baseline before antiretroviral therapy (ART) and to determine eligibility and follow-up of opportunistic infection prophylaxis. However, access to CD4+ T cell count in rural health facilities remains a major challenge in Ethiopi...

Full description

Bibliographic Details
Main Authors: Gebremedhin Gebremicael, Yohanes Belay, Fitsum Girma, Yemane Abreha, Atsbeha Gebreegziabxier, Simret Tesfaye, Zelalem Messele, Yibeltal Assefa, Bahrie Bellete, Desta Kassa, Lara Vojnov
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5407647?pdf=render